Explore All 557 Venture Life Science Deals - Search the Database Free
Investment Summary |
|
|---|---|
| Date | April 5, 2010 |
| Target | Altheos |
| Sector | Life Science |
| Investor(s) | Bay City Capital |
| Deal Type | Venture |
FILTER BY
| Category | Venture Capital Firm |
|---|---|
| Founded | 1997 |
| PE ASSETS | 1.3B USD |
| Size | Large |
| Type | Sector Focused |
Bay City Capital LLC was established in 1997 as an equal partnership between The Craves Group and certain Pritzker family business interests for the purpose of managing investment funds in the life sciences industry. Bay City looks for opportunities at all stages of development in biopharmaceuticals, drug discovery, medical devices and diagnostics. Bay City Capital is based in San Francisco, California.
| Deal Context for Investor | # |
|---|---|
| Overall | 59 of 75 |
| Sector: Life Science | 42 of 54 |
| Type: Venture | 40 of 49 |
| State: California | 32 of 41 |
| Country: United States | 56 of 72 |
| Year: 2010 | 3 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-02-18 |
BioSeek
South San Francisco, California, United States BioSeek is a pharmaceutical services. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-08-06 |
NuPathe
Malvern, Pennsylvania, United States NuPathe, Inc. is a pharmaceutical company focused on innovative neuroscience solutions for diseases of the central nervous system including neurological and psychiatric disorders. |
Sell | - |
